The comments were made during her hearing with the House Oversight Committee.
At present, EpiPens have a shelf life of 18 months. The new formulation would boost time between refills to two years.
Ms. Bresch said Canonsburg, Pa.-based Mylan has been working on the reformulation for two years and hopes to submit it to the Food and Drug Administration within days.
More articles on supply chain:
Mylan CEO defends price hikes during heated EpiPen hearing: 5 takeaways
Self-directed robots are the new warehouse workers
Athenahealth CEO: EpiPen price hikes shouldn’t be a political issue
